LNA-043
N/A
Report date: 2026/03/08 20:00:13
Base Information
Drug NameLNA-043
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[23]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesNovartis Pharma Ag
Inactive CompaniesLonza AGChina Novartis Institutes For Biomedical Research Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A